Editor of Pharmaceutical Technology Europe

Felicity Thomas

Articles

Efforts are already underway to harmonize standards and regulatory approaches for testing of raw and ancillary materials, but continuous improvement is required.

Regulating Raw Materials Testing

As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.

Sourcing Success in Cell and Gene Therapy Development

The commercialization of cell therapies is still at its infancy, but industry is facing an exciting period of development as the sector is expected to grow exponentially.

Cell Therapies: The Living End of Growth Opportunities

Biologics raise unique formulation and development challenges, and industry is still on a learning curve to get the best out of these diverse and complex therapies.

Author | Felicity Thomas